Podchaser Logo
Home
Enhancing Precision in Immunotherapy: CD8 PET-Avidity in RCC

Enhancing Precision in Immunotherapy: CD8 PET-Avidity in RCC

Released Friday, 1st March 2024
Good episode? Give it some love!
Enhancing Precision in Immunotherapy: CD8 PET-Avidity in RCC

Enhancing Precision in Immunotherapy: CD8 PET-Avidity in RCC

Enhancing Precision in Immunotherapy: CD8 PET-Avidity in RCC

Enhancing Precision in Immunotherapy: CD8 PET-Avidity in RCC

Friday, 1st March 2024
Good episode? Give it some love!
Rate Episode

In this episode of Emerging Experts, Peter Zang, MD, highlights research on baseline CD8 lymph node avidity with 89-Zr-crefmirlimab for the treatment of patients with metastatic renal cell carcinoma and response to immunotherapy. 

Show More
Rate

Join Podchaser to...

  • Rate podcasts and episodes
  • Follow podcasts and creators
  • Create podcast and episode lists
  • & much more

Episode Tags

Do you host or manage this podcast?
Claim and edit this page to your liking.
,

Unlock more with Podchaser Pro

  • Audience Insights
  • Contact Information
  • Demographics
  • Charts
  • Sponsor History
  • and More!
Pro Features